Adderall-XR

DRUG4 trials

Sponsors

New York State Psychiatric Institute, University of California, Los Angeles, Boston Children's Hospital

Conditions

ADHDAdult Attention Deficit Hyperactivity DisorderAttention-deficit/Hyperactivity DisorderCannabis Use DisorderCocaine DependenceMajor Depressive Disorder

Early Phase 1

Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder

Enrolling by invitationNCT04509102

University of California, Los AngelesMajor Depressive Disorder

Start: 2021-09-27End: 2027-12-01Target: 30Updated: 2026-02-03

Phase 1

Biomarkers of ADHD Treatment Response

CompletedNCT05650775

Boston Children's HospitalADHD

Start: 2023-02-17End: 2024-03-30Updated: 2024-12-18

Phase 2

Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence

CompletedNCT00553319

New York State Psychiatric InstituteAdult Attention Deficit Hyperactivity Disorder, Cocaine Dependence

Start: 2007-12-31End: 2013-07-31Updated: 2019-04-24

Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder

CompletedNCT02803229

New York State Psychiatric InstituteAttention-deficit/Hyperactivity Disorder, Cannabis Use Disorder

Start: 2016-07-31End: 2020-06-30Updated: 2021-04-09

Related Papers

Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder

JAMA Psychiatry2015-04-18168 citations